402 related articles for article (PubMed ID: 30889188)
1. Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study.
Lee Y; Mozaffarian D; Sy S; Huang Y; Liu J; Wilde PE; Abrahams-Gessel S; Jardim TSV; Gaziano TA; Micha R
PLoS Med; 2019 Mar; 16(3):e1002761. PubMed ID: 30889188
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of financial incentives and disincentives for improving food purchases and health through the US Supplemental Nutrition Assistance Program (SNAP): A microsimulation study.
Mozaffarian D; Liu J; Sy S; Huang Y; Rehm C; Lee Y; Wilde P; Abrahams-Gessel S; de Souza Veiga Jardim T; Gaziano T; Micha R
PLoS Med; 2018 Oct; 15(10):e1002661. PubMed ID: 30278053
[TBL] [Abstract][Full Text] [Related]
3. Health and Economic Impacts of the National Menu Calorie Labeling Law in the United States: A Microsimulation Study.
Liu J; Mozaffarian D; Sy S; Lee Y; Wilde PE; Abrahams-Gessel S; Gaziano T; Micha R;
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006313. PubMed ID: 32493057
[TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of the US Food and Drug Administration Added Sugar Labeling Policy for Improving Diet and Health.
Huang Y; Kypridemos C; Liu J; Lee Y; Pearson-Stuttard J; Collins B; Bandosz P; Capewell S; Whitsel L; Wilde P; Mozaffarian D; O'Flaherty M; Micha R;
Circulation; 2019 Jun; 139(23):2613-2624. PubMed ID: 30982338
[TBL] [Abstract][Full Text] [Related]
5. Health Impact and Cost-Effectiveness of Achieving the National Salt and Sugar Reduction Initiative Voluntary Sugar Reduction Targets in the United States: A Microsimulation Study.
Shangguan S; Mozaffarian D; Sy S; Lee Y; Liu J; Wilde PE; Sharkey AL; Dowling EA; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
Circulation; 2021 Oct; 144(17):1362-1376. PubMed ID: 34445886
[TBL] [Abstract][Full Text] [Related]
6. Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis.
Pearson-Stuttard J; Kypridemos C; Collins B; Mozaffarian D; Huang Y; Bandosz P; Capewell S; Whitsel L; Wilde P; O'Flaherty M; Micha R
PLoS Med; 2018 Apr; 15(4):e1002551. PubMed ID: 29634725
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of Financial Incentives for Patients and Physicians to Manage Low-Density Lipoprotein Cholesterol Levels.
Pandya A; Asch DA; Volpp KG; Sy S; Troxel AB; Zhu J; Weinstein MC; Rosenthal MB; Gaziano TA
JAMA Netw Open; 2018 Sep; 1(5):e182008. PubMed ID: 30646152
[TBL] [Abstract][Full Text] [Related]
8. Health and Economic Impacts of Implementing Produce Prescription Programs for Diabetes in the United States: A Microsimulation Study.
Wang L; Lauren BN; Hager K; Zhang FF; Wong JB; Kim DD; Mozaffarian D
J Am Heart Assoc; 2023 Aug; 12(15):e029215. PubMed ID: 37417296
[TBL] [Abstract][Full Text] [Related]
9. Health Impact and Cost-Effectiveness of Volume, Tiered, and Absolute Sugar Content Sugar-Sweetened Beverage Tax Policies in the United States: A Microsimulation Study.
Lee Y; Mozaffarian D; Sy S; Liu J; Wilde PE; Marklund M; Abrahams-Gessel S; Gaziano TA; Micha R
Circulation; 2020 Aug; 142(6):523-534. PubMed ID: 32564614
[TBL] [Abstract][Full Text] [Related]
10. Cardiometabolic disease costs associated with suboptimal diet in the United States: A cost analysis based on a microsimulation model.
Jardim TV; Mozaffarian D; Abrahams-Gessel S; Sy S; Lee Y; Liu J; Huang Y; Rehm C; Wilde P; Micha R; Gaziano TA
PLoS Med; 2019 Dec; 16(12):e1002981. PubMed ID: 31846453
[TBL] [Abstract][Full Text] [Related]
11. Reducing US cardiovascular disease burden and disparities through national and targeted dietary policies: A modelling study.
Pearson-Stuttard J; Bandosz P; Rehm CD; Penalvo J; Whitsel L; Gaziano T; Conrad Z; Wilde P; Micha R; Lloyd-Williams F; Capewell S; Mozaffarian D; O'Flaherty M
PLoS Med; 2017 Jun; 14(6):e1002311. PubMed ID: 28586351
[TBL] [Abstract][Full Text] [Related]
12. Implementing Lifestyle Change Interventions to Prevent Type 2 Diabetes in US Medicaid Programs: Cost Effectiveness, and Cost, Health, and Health Equity Impact.
Laxy M; Zhang P; Ng BP; Shao H; Ali MK; Albright A; Gregg EW
Appl Health Econ Health Policy; 2020 Oct; 18(5):713-726. PubMed ID: 32607728
[TBL] [Abstract][Full Text] [Related]
13. A social cost-benefit analysis of meat taxation and a fruit and vegetables subsidy for a healthy and sustainable food consumption in the Netherlands.
Broeks MJ; Biesbroek S; Over EAB; van Gils PF; Toxopeus I; Beukers MH; Temme EHM
BMC Public Health; 2020 May; 20(1):643. PubMed ID: 32389120
[TBL] [Abstract][Full Text] [Related]
14. Nationwide expansion of a financial incentive program on fruit and vegetable purchases among Supplemental Nutrition Assistance Program participants: A cost-effectiveness analysis.
An R
Soc Sci Med; 2015 Dec; 147():80-8. PubMed ID: 26547363
[TBL] [Abstract][Full Text] [Related]
15. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY; Ko SK; Liew D
Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
[TBL] [Abstract][Full Text] [Related]
16. FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness Analysis.
Collins B; Kypridemos C; Pearson-Stuttard J; Huang Y; Bandosz P; Wilde P; Kersh R; Capewell S; Mozaffarian D; Whitsel LP; Micha R; O'Flaherty M;
Milbank Q; 2019 Sep; 97(3):858-880. PubMed ID: 31332837
[TBL] [Abstract][Full Text] [Related]
17. Nutritional policy changes in the supplemental nutrition assistance program: a microsimulation and cost-effectiveness analysis.
Basu S; Seligman H; Bhattacharya J
Med Decis Making; 2013 Oct; 33(7):937-48. PubMed ID: 23811757
[TBL] [Abstract][Full Text] [Related]
18. Cost-Effectiveness of a Community-Based Diabetes Prevention Program with Participation Incentives for Medicaid Beneficiaries.
Gilmer T; O'Connor PJ; Schiff JS; Taylor G; Vazquez-Benitez G; Garrett JE; Vue-Her H; Rinn S; Anderson J; Desai J
Health Serv Res; 2018 Dec; 53(6):4704-4724. PubMed ID: 29770445
[TBL] [Abstract][Full Text] [Related]
19. Association of National Expansion of Insurance Coverage of Medically Tailored Meals With Estimated Hospitalizations and Health Care Expenditures in the US.
Hager K; Cudhea FP; Wong JB; Berkowitz SA; Downer S; Lauren BN; Mozaffarian D
JAMA Netw Open; 2022 Oct; 5(10):e2236898. PubMed ID: 36251292
[TBL] [Abstract][Full Text] [Related]
20. Estimated health benefits, costs, and cost-effectiveness of eliminating industrial trans-fatty acids in Australia: A modelling study.
Marklund M; Zheng M; Veerman JL; Wu JHY
PLoS Med; 2020 Nov; 17(11):e1003407. PubMed ID: 33137090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
